The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
  12. Cochrane Depression, Anxiety and Neurosis Group
    1. About this group
    2. Reviews
      1. Active placebos versus antidepressants for depressionReview
      2. Acupuncture for depressionReview
      3. Acupuncture for insomniaReview
      4. Agomelatine versus other antidepressive agents for major depressionReview
      5. Alprazolam for depressionReview
      6. Alternating current cranial electrotherapy stimulation (CES) for depressionReview
      7. Amitriptyline for depressionReview
      8. Amitriptyline versus placebo for major depressive disorderReview
      9. Antidepressant prevention of postnatal depressionReview
      10. Antidepressant treatment for postnatal depressionReview
      11. Antidepressants for anorexia nervosaReview
      12. Antidepressants for depressed elderlyReview
      13. Antidepressants for depression in medical illnessReviewWithdrawn
      14. Antidepressants for depression in physically ill peopleReview
      15. Antidepressants for generalised anxiety disorder (GAD)Review
      16. Antidepressants plus benzodiazepines for major depressionReview
      17. Antidepressants versus placebo for depression in primary careReview
      18. Antidepressants versus placebo for people with bulimia nervosaReview
      19. Antidepressants versus placebo for the depressed elderlyReview
      20. Antidepressants versus psychological treatments and their combination for bulimia nervosaReview
      21. Antiglucocorticoid treatments for mood disordersReviewWithdrawn
      22. Aripiprazole alone or in combination for acute maniaReview
      23. Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disordersReview
      24. Azapirones for generalized anxiety disorderReview
      25. Azapirones versus placebo for panic disorder in adultsReview
      26. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescentsReview
      27. Behavioural therapies versus other psychological therapies for depressionReview
      28. Citalopram versus other anti-depressive agents for depressionReview
      29. Cognitive behaviour therapy for chronic fatigue syndrome in adultsReview
      30. Cognitive behavioural therapy for anxiety disorders in children and adolescentsReview
      31. Collaborative care for depression and anxiety problemsReview
      32. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)Review
      33. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobiaReview
      34. Combined psychotherapy plus benzodiazepines for panic disorderReview
      35. Consultation letters for medically unexplained physical symptoms in primary careReview
      36. Continuation and maintenance treatments for depression in older peopleReviewComment
      37. Counselling for mental health and psychosocial problems in primary careReview
      38. Dance movement therapy for depressionReview
      39. Debriefing interventions for the prevention of psychological trauma in women following childbirthReview
      40. Drugs versus placebo for dysthymiaReviewWithdrawn
      41. Duloxetine versus other anti-depressive agents for depressionReview
      42. Early psychological interventions to treat acute traumatic stress symptomsReview
      43. Electroconvulsive therapy for the depressed elderlyReview
      44. Enhanced care by generalists for functional somatic symptoms and disorders in primary careReview
      45. Escitalopram versus other antidepressive agents for depressionReview
      46. Exercise for depressionReview
      47. Exercise in prevention and treatment of anxiety and depression among children and young peopleReview
      48. Exercise therapy for chronic fatigue syndromeReview
      49. Family interventions for bipolar disorderReview
      50. Family therapy for anorexia nervosaReview
      51. Family therapy for depressionReview
      52. Fluoxetine versus other types of pharmacotherapy for depressionReview
      53. Fluvoxamine versus other anti-depressive agents for depressionReview
      54. Folate for depressive disordersReview
      55. Haloperidol alone or in combination for acute maniaReview
      56. Hydroxyzine for generalised anxiety disorderReview
      57. Individual psychotherapy in the outpatient treatment of adults with anorexia nervosaReview
      58. Inositol for depressive disordersReview
      59. Interventions for helping people recognise early signs of recurrence in bipolar disorderReview
      60. Interventions for pathological gamblingReviewWithdrawn
      61. Interventions for preventing eating disorders in children and adolescentsReview
      62. Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescentsReview
      63. Interventions for vaginismusReview
      64. Interventions to facilitate return to work in adults with adjustment disordersReview
      65. Kava extract versus placebo for treating anxietyReview
      66. Light therapy for non-seasonal depressionReview
      67. Lithium for maintenance treatment of mood disordersReview
      68. Lithium versus antidepressants in the long-term treatment of unipolar affective disorderReview
      69. Low dosage tricyclic antidepressants for depressionReview
      70. Marital therapy for depressionReview
      71. Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adultsReview
      72. Meditation therapy for anxiety disordersReview
      73. Melatonin for the prevention and treatment of jet lagReview
      74. Milnacipran versus other antidepressive agents for depressionReview
      75. Mirtazapine versus other antidepressive agents for depressionReview
      76. Morita therapy for anxiety disorders in adultsReview
      77. Multiple session early psychological interventions for the prevention of post-traumatic stress disorderReview
      78. Music therapy for depressionReview
      79. Newer generation antidepressants for depressive disorders in children and adolescentsReview
      80. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adultsReview
      81. Olanzapine alone or in combination for acute maniaReview
      82. Olanzapine in long-term treatment for bipolar disorderReview
      83. Omega-3 fatty acids for bipolar disorderReview
      84. Oxcarbazepine for acute affective episodes in bipolar disorderReview
      85. Oxcarbazepine in the maintenance treatment of bipolar disorderReview
      86. Paraprofessionals for anxiety and depressive disordersReview
      87. Paroxetine versus other anti-depressive agents for depressionReview
      88. Passiflora for anxiety disorderReview
      89. Pharmacological interventions for preventing post-traumatic stress disorder (PTSD)Review
      90. Pharmacological interventions for somatoform disorders in adultsReview
      91. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary diseaseReview
      92. Pharmacological treatment for psychotic depressionReview
      93. Pharmacotherapy and psychotherapy for body dysmorphic disorderReview
      94. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disordersReview
      95. Pharmacotherapy for anxiety and comorbid alcohol use disordersReview
      96. Pharmacotherapy for anxiety disorders in children and adolescentsReview
      97. Pharmacotherapy for dysthymiaReview
      98. Pharmacotherapy for post traumatic stress disorder (PTSD)Review
      99. Pharmacotherapy for social anxiety disorderReview
      100. Pharmacotherapy for trichotillomaniaReview
      101. Psychological and educational interventions for preventing depression in children and adolescentsReview
      102. Psychological debriefing for preventing post traumatic stress disorder (PTSD)Review
      103. Psychological, social and welfare interventions for psychological health and well-being of torture survivorsReview
      104. Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adultsReview
      105. Psychological therapies for generalised anxiety disorderReview
      106. Psychological therapies for pathological and problem gamblingReview
      107. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescentsReview
      108. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsReview
      109. Psychological treatments for bulimia nervosa and bingingReview
      110. Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD)Review
      111. Psychosocial and pharmacological treatments for deliberate self harmReview
      112. Psychosocial and psychological interventions for treating postpartum depressionReview
      113. Psychosocial interventions by general practitionersReview
      114. Psychosocial interventions for conversion disorderReview
      115. Psychosocial interventions for prevention of psychological disorders in law enforcement officersReview
      116. Psychostimulants for depressionReview
      117. Psychotherapeutic treatments for older depressed peopleReview
      118. Psychotherapies for hypochondriasisReview
      119. Reiki for depression and anxietyReview
      120. Relaxation for depressionReview
      121. Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adultsReview
      122. Risperidone alone or in combination for acute maniaReview
      123. Risperidone in long-term treatment for bipolar disorderReview
      124. Screening and case finding instruments for depressionReview
      125. Second-generation antidepressants for seasonal affective disorderReview
      126. Second-generation antipsychotics for anxiety disordersReview
      127. Second-generation antipsychotics for major depressive disorder and dysthymiaReview
      128. Second-generation antipsychotics for obsessive compulsive disorderReview
      129. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)Review
      130. Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depressionReviewWithdrawn
      131. Self-help and guided self-help for eating disordersReview
      132. Sertraline versus other antidepressive agents for depressionReview
      133. Short-term psychodynamic psychotherapies for common mental disordersReview
      134. Sports and games for post-traumatic stress disorder (PTSD)Review
      135. St John's wort for major depressionReview
      136. Strategies for managing sexual dysfunction induced by antidepressant medicationReview
      137. Therapeutic touch for anxiety disordersReview
      138. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adultsReview
      139. 'Third wave' cognitive and behavioural therapies versus other psychological therapies for depressionReview
      140. 'Third wave' cognitive and behavioural therapies versus treatment as usual for depressionReview
      141. Tiagabine for acute affective episodes in bipolar disorderReview
      142. Tiagabine in the maintenance treatment of bipolar disorderReview
      143. Topiramate for acute affective episodes in bipolar disorderReview
      144. Traditional Chinese medicinal herbs for the treatment of idiopathic chronic fatigue and chronic fatigue syndromeReview
      145. Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorderReview
      146. Transcranial magnetic stimulation for treating depressionReview
      147. Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)ReviewWithdrawn
      148. Tricyclic drugs for depression in children and adolescentsReview
      149. Tryptophan and 5-Hydroxytryptophan for depressionReview
      150. Valerian for anxiety disordersReview
      151. Valproate for acute mood episodes in bipolar disorderReview
      152. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorderReview
    3. Protocols
      1. Adjunctive antioxidants for bipolar disorderProtocol
      2. Antidepressants and benzodiazepines for panic disorder in adultsProtocol
      3. Antidepressants for depression during pregnancyProtocol
      4. Antidepressants for insomniaProtocol
      5. Antidepressants versus placebo for panic disorder in adultsProtocol
      6. Antipsychotic drugs for anorexia nervosaProtocol
      7. Behavioural and cognitive-behavioural therapy based self-help versus treatment as usual for depression in adults and adolescentsProtocolNew
      8. Behavioural therapies versus treatment as usual for depressionProtocol
      9. Benzodiazepines and related drugs for older depressed peopleProtocol
      10. Benzodiazepines for generalised anxiety disorder (GAD)Protocol
      11. Benzodiazepines versus placebo for panic disorder in adultsProtocol
      12. Bibliotherapy for sexual dysfunctionProtocol
      13. Bupropion versus other antidepressive agents for depressionProtocol
      14. Client feedback in psychological therapy for children and adolescents with mental health problemsProtocolNew
      15. Cognitive behavioural therapies versus other psychological therapies for depressionProtocol
      16. Cognitive behavioural therapies versus treatment as usual for depressionProtocol
      17. Cognitive behavioural therapy for anxiety disorders in later lifeProtocol
      18. Cognitive behavioural therapy for insomniaProtocolWithdrawn
      19. Couple and family therapies for post-traumatic stress disorder (PTSD)Protocol
      20. Electroconvulsive therapy for depressionProtocol
      21. Eszopiclone for insomniaProtocol
      22. Exercise therapy for chronic fatigue syndrome (individual patient data)Protocol
      23. Humanistic therapies versus other psychological therapies for depressionProtocol
      24. Humanistic therapies versus treatment as usual for depressionProtocol
      25. Inpatient versus outpatient care, partial hospitalisation and wait-list for people with eating disordersProtocol
      26. Internet-based cognitive and behavioural therapies for post-traumatic stress disorder (PTSD) in adultsProtocol
      27. Interpersonal, cognitive analytic and other integrative therapies versus other psychological therapies for depressionProtocol
      28. Interpersonal, cognitive analytic and other integrative therapies versus treatment as usual for depressionProtocol
      29. Interventions for helping people recognise early signs of recurrence in depressionProtocol
      30. Interventions for mood and anxiety disorders, and self harm in young offendersProtocol
      31. Ketamine and other glutamate receptor modulators for depression in adultsProtocol
      32. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adultsProtocol
      33. Light therapy for preventing seasonal affective disorderProtocol
      34. Melatonin and agomelatine for preventing seasonal affective disorderProtocol
      35. Newer anticonvulsants in the treatment of anxiety disordersProtocol
      36. Omega-3 fatty acids for depression in adultsProtocol
      37. Pharmacological interventions for adjustment disorders in adultsProtocol
      38. Pharmacological interventions for the treatment of pathological and problem gamblingProtocol
      39. Pharmacological interventions for treatment-resistant depression in adultsProtocol
      40. Pharmacotherapy for bipolar disorder in older peopleProtocol
      41. Postdischarge interventions for depressionProtocol
      42. Prevention of depression in chronically physically ill adultsProtocol
      43. Prevention of suicide and suicidal behaviour in adolescentsProtocol
      44. Psychodynamic therapies versus other psychological therapies for depressionProtocol
      45. Psychodynamic therapies versus treatment as usual for depressionProtocol
      46. Psychological interventions for post-traumatic stress disorder and comorbid substance use disorderProtocol
      47. Psychological therapies for panic disorder with or without agoraphobia in adultsProtocol
      48. Psychological therapies for preventing seasonal affective disorderProtocol
      49. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary diseaseProtocol
      50. Psychological therapies for treatment-resistant depression in adultsProtocol
      51. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adultsProtocol
      52. Psychosocial interventions for prevention of depression in older peopleProtocol
      53. Psychotherapy for depression in children and adolescentsProtocol
      54. Ramelteon for insomniaProtocol
      55. Reboxetine versus other antidepressive agents for depressionProtocol
      56. Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adultsProtocol
      57. S-adenosyl methionine (SAM-e) for depression in adultsProtocol
      58. Second-generation antidepressants for preventing seasonal affective disorderProtocol
      59. Self-report screening instruments for post-traumatic stress disorder (PTSD) in survivors of traumatic experiencesProtocolDiagnostic
      60. Specific psychological therapies versus other therapies or no treatment for severe and enduring anorexia nervosaProtocol
      61. Therapist-delivered distance cognitive behavioural therapy for anxiety disorders in adultsProtocol
      62. Transcranial magnetic stimulation for post-traumatic stress disorderProtocol
      63. Venlafaxine versus other anti-depressive agents for depressionProtocol
      64. Vortioxetine for depression in adultsProtocol
      65. Zaleplon for insomniaProtocol
      66. Zolpidem for insomniaProtocol
      67. Zopiclone for insomniaProtocol
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
  53. Cochrane Wounds Group

SEARCH